Skip to content

Research on Multi-target iTBS-Multimodal BCI Cooperative Regulation of Stroke-Affected Hand Function Rehabilitation and Network Functional Connectivity Based on Motor Intent Decoding

Research on Multi-target iTBS-Multimodal BCI Cooperative Regulation of Stroke-Affected Hand Function Rehabilitation and Network Functional Connectivity Based on Motor Intent Decoding

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117435
Enrollment
Unknown
Registered
2026-01-23
Start date
2026-02-10
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Control group:iTBS sham stimulation + BCI
Experimental group 1:M1-iTBS+BCI
Experimental group 2:DLPFC+M1-iTBS+BCI

Sponsors

Longgang District People's Hospital of Shenzhen
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with stroke confirmed by CT or MRI; 2. Patients with unilateral hemiplegia after their first stroke, with a course of stroke >1 week; or patients with recurrent stroke who had no sequelae from the first stroke, but now have unilateral hemiplegia, with a course of stroke >1 week; 3. Accompanied by moderate to severe hand dysfunction (Brunnstrom <= Grade 4, MAS <= Grade 3); 4. No severe cognitive impairment and able to perform hand grasping and other movements following instructions; 5. No severe cardiovascular, pulmonary, liver, or kidney dysfunction, no history of drug or alcohol dependence, or other serious diseases affecting brain structure and function, and no severe psychiatric disorders; 6. Able to sit independently or with support for more than 1 hour and voluntarily willing to participate.

Exclusion criteria

Exclusion criteria: 1. History of two or more strokes with residual effects; 2. Presence of limb dysfunction caused by other reasons before onset; 3. Complicated with severe cardiopulmonary, liver, kidney, or hematological complications; 4. Other neurological diseases, inability to cooperate with training, or poor treatment adherence; 5. Cognitive impairments, or visual or hearing impairments; 6. Sensory aphasia or mixed aphasia affecting patient communication; 7. Unstable fractures, infections, or active bleeding in the affected hand; 8. History of seizures in the past three months.

Design outcomes

Primary

MeasureTime frame
Upper Limb Fugl-Meyer Assessment (FMA-UE);Activities of Routine Activities Test (ARAT);Wolf Motor Function Test (WMFT) Score;Modified Barthel Index;

Secondary

MeasureTime frame
Near-infrared brain functional imaging to detect changes in hemoglobin concentration;Blood Oxygen Level Dependent Magnetic Resonance Imaging (BOLD-fMRI);Diffusion tensor imaging(DTI);Resting-state electroencephalogram (EEG) and event-related desynchronisation (ERD) characteristics;

Countries

China

Contacts

Public ContactBenguo Wang

Longgang District People's Hospital of Shenzhen

wbg2001qq@126.com+86 135 2826 5815

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026